CD8A and neoplasm: In accordance to these in vitro findings, when we adoptively transferred intratumoral CD8+ T cells from Wnt1-OVA-LLC tumors to recipient mice bearing established subcutaneous OVA-LLC tumors (secondary transfer), we observed low proliferation rates of intratumoral OTI T cells and enhanced tumor growth (Fig. 3i).